Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Francisco Alvarez-Lerma"'
Autor:
Martin Wolkewitz, Ben S. Cooper, Mercedes Palomar-Martinez, Francisco Alvarez-Lerma, Pedro Olaechea-Astigarraga, Adrian G. Barnett, Martin Schumacher
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-11 (2016)
Abstract Background When patients are admitted to an intensive care unit (ICU) their risk of getting an infection will be highly depend on the length of stay at-risk in the ICU. In addition, risk of infection is likely to vary over calendar time as a
Externí odkaz:
https://doaj.org/article/437c6f003ed14ecc81d0e7ccb87062a8
Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project
Autor:
Gennaro De Pascale, Otavio T. Ranzani, Saad Nseir, Jean Chastre, Tobias Welte, Massimo Antonelli, Paolo Navalesi, Eugenio Garofalo, Andrea Bruni, Luis Miguel Coelho, Szymon Skoczynski, Federico Longhini, Fabio Silvio Taccone, David Grimaldi, Helmut J.F. Salzer, Christoph Lange, Filipe Froes, Antoni Artigas, Emili Díaz, Jordi Vallés, Alejandro Rodríguez, Mauro Panigada, Vittoria Comellini, Luca Fasano, Paolo M. Soave, Giorgia Spinazzola, Charles-Edouard Luyt, Francisco Alvarez-Lerma, Judith Marin, Joan Ramon Masclans, Davide Chiumello, Angelo Pezzi, Marcus Schultz, Hafiz Mohamed, Menno Van Der Eerden, Roger A.S. Hoek, D.A.M.P.J. Gommers, Marta Di Pasquale, Rok Civljak, Marko Kutleša, Matteo Bassetti, George Dimopoulos, Stefano Nava, Fernando Rios, Fernando G. Zampieri, Pedro Povoa, Lieuwe D. Bos, Stefano Aliberti, Antoni Torres, Ignacio Martín-Loeches
Publikováno v:
ERJ Open Research, Vol 3, Iss 4 (2017)
The clinical course of intensive care unit (ICU) patients may be complicated by a large spectrum of lower respiratory tract infections (LRTI), defined by specific epidemiological, clinical and microbiological aspects. A European network for ICU-relat
Externí odkaz:
https://doaj.org/article/68d61dbc1ad54607b344639171919e9c
Publikováno v:
Drug Design, Development and Therapy, Vol 2009, Iss default, Pp 173-190 (2009)
Francisco Alvarez-Lerma1, Santiago Grau2, Olivia Ferrández21Intensive Care Unit, 2Pharmacy Department, Hospital Del Mar, Barcelona, SpainAbstract: Doripenem (S-4661) is a new parenteral antibiotic from the carbapenem class; similarly to imipenem and
Externí odkaz:
https://doaj.org/article/75c9a2a0ff904b6fa855d9bad04a22d4
Autor:
Pablo Vidal-Cortés, Ignacio Martin-Loeches, Rafael Zaragoza, Marcio Borges, M.P. Gracia Arnillas, M. Catalán González, P. Ramírez, D. Andaluz Ojeda, B. Suberviola, Xavier Nuvials, Francisco Alvarez-Lerma, A. Rodríguez, Angel Estella, E. Díaz
Publikováno v:
Medicina Intensiva
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Las infecciones se han convertido en una de las principales complicaciones de los pacientes con neumonía grave por SARS-CoV-2 que ingresan en UCI. El deficiente estado inmunitario, el desarrollo frecuente de fracaso orgánico con necesidad de tratam
El impacto negativo de la pandemia sobre las tasas de infecciones controladas ha evidenciado la necesidad de reanudar la aplicación de las recomendaciones de los Proyectos Zero (PZ). En este artículo, en primer lugar, se realiza un análisis de la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a933d2a7e440648bc949c343968e03
https://hdl.handle.net/10171/65795
https://hdl.handle.net/10171/65795
Autor:
Jaume Roquer, Francisco Alvarez-Lerma, Angel Ois, Maria Pilar Gracia Arnillas, Xavi Duran, Elisa Cuadrado, Demian Manzano, Carolina Soriano, Ans Zapatero, Andrea Castellví, Yolanda Diaz, Jose Ramón Masclans
Publikováno v:
European journal of clinical investigationREFERENCES. 50(11)
PURPOSE To use classification tree analysis to identify risk factors for nonsurvival in a neurological patients with subarachnoid haemorrhage (SAH) and to propose a clinical model for predicting of mortality. METHODS Prospective study of SAH admitted
Autor:
María Martín-Cerezuela, Maialen Aseginolaza-Lizarazu, Patricia Boronat-García, María José Asensio-Martín, Gisela Alamán-Laguarda, Francisco Álvarez-Lerma, David Roa-Alonso, Lorenzo Socias, Paula Vera-Artázcoz, Paula Ramírez-Galleymore, the Grupo de Trabajo en Infección y Sepsis (GTEIS) from the Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC)
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-8 (2023)
Abstract Background Severe community-acquired pneumococcal meningitis is a medical emergency. The aim of the present investigation was to evaluate the epidemiology, management and outcomes of this condition. Methods This was a retrospective, observat
Externí odkaz:
https://doaj.org/article/66e2c0552c5b458f89985a3e315f95ce
Autor:
Fernando, Callejo-Torre, Jose Maria, Eiros Bouza, Pedro, Olaechea Astigarraga, Maria Jesus, Coma Del Corral, Mercedes, Palomar Martínez, Francisco, Alvarez-Lerma, Maria Jesús, López-Pueyo
Publikováno v:
Le infezioni in medicina. 24(3)
Predicting methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units (ICUs) avoids inappropriate antimicrobial empirical treatment and enhances infection control. We describe risk factors for colonisation/infection related to MRSA (M
Autor:
Maja, von Cube, Martin, Schumacher, Mercedes, Palomar-Martinez, Pedro, Olaechea-Astigarraga, Francisco, Alvarez-Lerma, Martin, Wolkewitz
Publikováno v:
Statistics in medicine. 36(3)
Analysing the determinants and consequences of hospital-acquired infections involves the evaluation of large cohorts. Infected patients in the cohort are often rare for specific pathogens, because most of the patients admitted to the hospital are dis
Autor:
Stephanie John, Pierre-François Laterre, Dolores Marzo, Xavier Wittebole, Daniel De Backer, Haruji Nakamura, Hajo A. Bruining, Jonathan Cohen, Stephen J. Brett, Jean Louis Vincent, Francisco Alvarez Lerma, Hilmar Burchardi
Publikováno v:
Shock. 23:400-405
Endotoxin is an important pathogenic trigger for sepsis. The polymyxin B-immobilized endotoxin removal hemoperfusion cartridge, Toraymyxin (hereafter PMX), has been shown to remove endotoxin in preclinical and open-label clinical studies. In a multic